Prestige's Monistat, Summer's Eve Brands Key Drivers In Consumer Health Focus
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
BC and Goody's OTC acetaminophen formulations perhaps are the firm's most known consumer health brands but they account for 12% of its revenues while its Monistat and Summer's Eve brands drove 27% of its sales in its latest quarter. The feminine hygiene brands' contribution, says a Jefferies analyst , will only grow with the firm selling its household care brands to focus entirely on the consumer health market.
You may also be interested in...
Deal For TheraTears Emphasizes Prestige Is A Consumer Health Business, Akorn Isn't
Both firms announce agreement for Prestige to pay Akorn $230m cash for TheraTear, Diabetic Tussin and Zostrix OTCs and MagOx and Multi-betic supplements. Akorn says the agreement is "to sell its Consumer Health business,” even though it retains two consumer brands.
Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning
Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.
Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform
Prestige Brands makes the deal three weeks after divesting the slower-selling Massengill douche brand and as it makes a top marketing priority of growing sales of its Monistat yeast treatment line.